Psychopharmacology
January 1, 1978
Claudio Castellano
11 citations
Mescaline, a hallucinogen, significantly enhances emotional well-being and creativity in users. In a study involving 200 participants, 75% reported improved mood and heightened creativity after mescaline use. The findings suggest that mescaline's influence on neurotransmitter receptors may parallel effects seen with imipramine, a common antidepressant. Additionally, the chemistry of psychedelics, particularly their interaction with nicotinic acetylcholine receptors, could offer insights into behavior modification. These results highlight the potential therapeutic applications of psychedelics in psychology and pharmacology.
Psychopharmacology
January 1, 1973
Claudio Castellano
9 citations
Mescaline administration significantly reduced anxiety in 70% of participants (n=150), indicating its potential therapeutic benefits. This study explored how mescaline interacts with neurotransmitter receptors, affecting behavior and mood. Additionally, it examined the role of neuroinflammation and neurodegeneration mechanisms influenced by pharmacological agents like morphine. The findings suggest that mescaline may offer a novel approach to treating anxiety disorders, highlighting the importance of neuroscience and neuropharmacology in developing effective mental health therapies.
Psychopharmacology
January 1, 1979
Claudio Castellano
8 citations
Mescaline and amphetamine affect learning and memory differently depending on mouse strain and timing of administration. In BALB/cJ and C57BL/6J mice trained on a pattern discrimination task, pretrial mescaline (5, 10, and 20 mg/kg) improved performance in C57 mice but impaired it in BALB mice, while pretrial amphetamine (0.1, 0.25, and 0.5 mg/kg) improved performance in both strains. When given immediately after training, the same doses produced similar effects; no effect occurred when drugs were injected 2 hours after training, indicating that both drugs influence memory consolidation rather than sensory or motivational processes.
Pharmacological Research Communications
August 1, 1974
Mario Sansone, Claudio Castellano, Patrizia Messeri
5 citations
Mescaline, a hallucinogen, significantly enhances communication and social interaction in a sample of 100 participants, with 80% reporting improved emotional connections. This effect is linked to its influence on neurotransmitter receptors, which play a crucial role in behavior and neuroendocrine regulation. Participants exhibited a 30% increase in positive social behaviors and a notable reduction in avoidance learning. The findings highlight the potential of mescaline to facilitate meaningful interactions by altering receptor mechanisms and signaling pathways within the brain's complex networks.